Heron Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Heron Therapeuti
HRTX Stock  USD 1.69  0.04  2.31%   
Heron Therapeuti's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Heron Therapeuti's valuation are provided below:
Gross Profit
95.5 M
Profit Margin
(0.05)
Market Capitalization
264 M
Enterprise Value Revenue
2.5832
Revenue
148.5 M
We have found one hundred twenty available fundamental trends for Heron Therapeuti, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Heron Therapeuti regular market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 849.6 M in 2025. Enterprise Value is likely to rise to about 914.8 M in 2025

Heron Therapeuti Total Revenue

151.5 Million

Check Heron Therapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heron Therapeuti's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.6 M, Interest Expense of 6.3 M or Total Revenue of 151.5 M, as well as many indicators such as Price To Sales Ratio of 1.54, Dividend Yield of 0.0 or Days Sales Outstanding of 112. Heron financial statements analysis is a perfect complement when working with Heron Therapeuti Valuation or Volatility modules.
  
Build AI portfolio with Heron Stock
Check out the analysis of Heron Therapeuti Correlation against competitors.
For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.

Heron Therapeuti Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets244.8 M233.1 M204.6 M
Slightly volatile
Short and Long Term Debt Total186.7 M177.8 M62.5 M
Slightly volatile
Other Current Liabilities80.5 M76.7 M45.3 M
Slightly volatile
Total Current Liabilities96 M91.5 M56.4 M
Slightly volatile
Property Plant And Equipment Net18.5 M17.6 M14.9 M
Slightly volatile
Cash27.8 M25.8 M53.9 M
Very volatile
Non Current Assets Total25.3 M24.1 M18.5 M
Slightly volatile
Non Currrent Assets Other6.8 M6.5 M3.6 M
Slightly volatile
Cash And Short Term Investments61 M59.3 M122.6 M
Pretty Stable
Net Receivables82.8 M78.9 M31.3 M
Slightly volatile
Common Stock Shares Outstanding160.1 M152.4 M68.4 M
Slightly volatile
Liabilities And Stockholders Equity244.8 M233.1 M204.6 M
Slightly volatile
Other Stockholder Equity2 B1.9 B1.1 B
Slightly volatile
Total Liabilities280.1 M266.8 M114.4 M
Slightly volatile
Property Plant And Equipment Gross37.3 M35.5 M18.3 M
Slightly volatile
Total Current Assets219.5 M209 M186.1 M
Slightly volatile
Short Term Debt3.9 M3 M5.3 M
Pretty Stable
Other Current Assets18.6 M17.7 M13.7 M
Slightly volatile
Accounts Payable12.3 M11.7 M5.6 M
Slightly volatile
Common Stock Total Equity658 K1.2 M915.3 K
Very volatile
Common Stock1.6 M1.5 M1 M
Pretty Stable
Other Liabilities263.3 K277.1 K18.9 M
Slightly volatile
Other Assets19 M18.1 M6.5 M
Slightly volatile
Property Plant Equipment36 M34.3 M15.3 M
Slightly volatile
Current Deferred Revenue3.3 M3.2 M1.9 M
Slightly volatile
Capital Surpluse2 B1.9 B1.1 B
Slightly volatile
Short and Long Term Debt8.3 M8.1 M6 M
Slightly volatile
Long Term Debt Total109.5 M171.4 M104.7 M
Slightly volatile
Non Current Liabilities Other584.2 K615 K25.7 M
Slightly volatile
Net Invested Capital185.8 M141.1 M197.7 M
Pretty Stable
Net Working Capital160.7 M117.6 M165.1 M
Pretty Stable
Capital Stock1.2 M1.5 M957.5 K
Slightly volatile
Capital Lease Obligations2.9 M3 M11.9 M
Slightly volatile

Heron Therapeuti Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization2.6 M2.5 M1.6 M
Slightly volatile
Other Operating Expenses87.1 M155.8 M170.7 M
Slightly volatile
Cost Of Revenue40.6 M38.6 M32.1 M
Slightly volatile
Total Operating Expenses73.5 M117.2 M144.9 M
Slightly volatile
Research Development15.8 M16.7 M76.8 M
Slightly volatile
Selling General Administrative56.1 M53.4 M31.3 M
Slightly volatile
Selling And Marketing Expenses62.7 M47.1 M45.3 M
Slightly volatile
Interest Income2.6 M3.5 M2.8 M
Pretty Stable
Reconciled Depreciation2.7 M2.5 M2 M
Slightly volatile

Heron Therapeuti Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow27.9 M28.7 M51.9 M
Pretty Stable
Depreciation2.6 M2.5 M1.6 M
Slightly volatile
Capital Expenditures1.8 M1.7 M2.8 M
Pretty Stable
Total Cash From Financing Activities893 K940 K95.7 M
Very volatile
End Period Cash Flow28.5 M25.8 M53.1 M
Very volatile
Stock Based Compensation24.1 M13 M24.6 M
Slightly volatile
Sale Purchase Of Stock7.7 M8.1 M75.2 M
Very volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.541.6166133
Slightly volatile
Days Sales Outstanding112200336
Slightly volatile
Stock Based Compensation To Revenue0.08530.08986.9454
Slightly volatile
Capex To Depreciation1.160.68462.3476
Slightly volatile
EV To Sales2.542.6698140
Slightly volatile
Inventory Turnover0.690.7270.7281
Slightly volatile
Days Of Inventory On Hand47750221.1 K
Slightly volatile
Payables Turnover3.143.300713.2534
Pretty Stable
Sales General And Administrative To Revenue0.350.37015.8378
Slightly volatile
Average Inventory70.2 K73.9 K207.2 K
Slightly volatile
Research And Ddevelopement To Revenue0.110.115626.8034
Slightly volatile
Capex To Revenue0.01120.01180.8571
Slightly volatile
Cash Per Share0.370.388911.5748
Slightly volatile
Days Payables Outstanding1051114.7 K
Very volatile
Intangibles To Total Assets0.0250.04980.0512
Very volatile
Current Ratio2.172.28545.8623
Slightly volatile
Receivables Turnover1.741.82911.5402
Slightly volatile
Capex Per Share0.01060.01120.4215
Slightly volatile
Revenue Per Share0.90.94641.5619
Slightly volatile
Interest Debt Per Share1.151.20562.4707
Slightly volatile
Debt To Assets0.80.76250.2975
Slightly volatile
Graham Number452431450
Slightly volatile
Operating Cycle66770221.5 K
Slightly volatile
Days Of Payables Outstanding1051114.7 K
Very volatile
Ebt Per Ebit0.751.1780.9959
Very volatile
Long Term Debt To Capitalization1.31.23851.1609
Pretty Stable
Total Debt To Capitalization1.31.23350.4747
Slightly volatile
Quick Ratio1.621.70415.5917
Slightly volatile
Net Income Per E B T0.920.850.9487
Slightly volatile
Cash Ratio0.270.28214.1363
Slightly volatile
Days Of Inventory Outstanding47750221.1 K
Slightly volatile
Days Of Sales Outstanding112200336
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.241.07571.0585
Very volatile
Fixed Asset Turnover8.588.17482.9523
Slightly volatile
Debt Ratio0.80.76250.2975
Slightly volatile
Price Sales Ratio1.541.6166133
Slightly volatile
Asset Turnover0.410.61890.2097
Slightly volatile
Gross Profit Margin0.520.73210.7477
Slightly volatile

Heron Therapeuti Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap849.6 M809.1 M811.7 M
Slightly volatile
Enterprise Value914.8 M871.2 M800.9 M
Slightly volatile

Heron Fundamental Market Drivers

Cash And Short Term Investments59.3 M

Heron Upcoming Events

28th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Heron Therapeuti Financial Statements

Heron Therapeuti investors use historical fundamental indicators, such as Heron Therapeuti's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Heron Therapeuti. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue3.2 M3.3 M
Total Revenue144.3 M151.5 M
Cost Of Revenue38.6 M40.6 M
Stock Based Compensation To Revenue 0.09  0.09 
Sales General And Administrative To Revenue 0.37  0.35 
Research And Ddevelopement To Revenue 0.12  0.11 
Capex To Revenue 0.01  0.01 
Revenue Per Share 0.95  0.90 
Ebit Per Revenue(0.08)(0.08)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
USOICredit Suisse X Links
ULTYTidal Trust II
CONYYieldMax N Option

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY